CVS HEALTH Corp (CVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 150B 300B 450B FY16: 177.5B FY17: 184.8B FY18: 193.9B FY19: 256.8B FY20: 268.7B FY21: 292.1B FY22: 322.5B FY23: 357.8B FY24: 372.8B FY25: 402.1B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 10B 20B 30B FY08: 18.3B FY09: 20.4B FY10: 20.2B FY11: 20.6B FY12: 22.5B FY13: 23.8B FY14: 25.4B FY15: 26.5B FY16: 28.9B FY17: 28.5B FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17

Operating Income Annual

0 5B 10B 15B FY16: 10.4B FY17: 9.5B FY18: 4B FY19: 12B FY20: 13.9B FY21: 13.3B FY22: 8B FY23: 13.7B FY24: 8.5B FY25: 4.7B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-3B 0 3B 6B 9B FY16: 5.3B FY17: 6.6B FY18: -594M FY19: 6.6B FY20: 7.2B FY21: 8B FY22: 4.3B FY23: 8.3B FY24: 4.6B FY25: 1.8B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 80B 160B 240B FY16: 146.5B FY17: 153.4B FY18: 156.4B FY19: 158.7B FY20: 164B FY21: 175.8B FY22: 196.9B FY23: 217.1B FY24: 206.3B FY25: 221.2B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

0 7B 14B 21B FY16: 10.1B FY17: 8B FY18: 8.9B FY19: 12.8B FY20: 15.9B FY21: 18.3B FY22: 16.2B FY23: 13.4B FY24: 9.1B FY25: 10.6B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

0 6B 12B 18B FY16: 7.9B FY17: 6.1B FY18: 6.8B FY19: 10.4B FY20: 13.4B FY21: 15.7B FY22: 13.4B FY23: 10.4B FY24: 6.3B FY25: 7.8B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 500M 1B 1.5B FY16: 1.1B FY17: 1B FY18: 1B FY19: 1.3B FY20: 1.3B FY21: 1.3B FY22: 1.3B FY23: 1.3B FY24: 1.3B FY25: 1.3B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.50 0.00 2.50 5.00 7.50 Q3 '16: 4.67 Q4 '16: 4.92 Q1 '17: 4.80 Q2 '17: 5.01 Q3 '17: 4.84 Q4 '17: 6.47 Q1 '18: 6.53 Q2 '18: 2.94 Q3 '18: 3.04 Q4 '18: -0.55 Q1 '19: -0.44 Q2 '19: 3.57 Q3 '19: 3.38 Q4 '19: 5.08 Q1 '20: 5.52 Q2 '20: 6.29 Q3 '20: 6.05 Q4 '20: 5.46 Q1 '21: 5.61 Q2 '21: 5.45 Q3 '21: 5.72 Q4 '21: 6.02 Q1 '22: 6.11 Q2 '22: 6.30 Q3 '22: 2.51 Q4 '22: 3.26 Q1 '23: 3.14 Q2 '23: 2.33 Q3 '23: 6.67 Q4 '23: 6.47 Q1 '24: 5.70 Q2 '24: 5.63 Q3 '24: 3.95 Q4 '24: 3.67 Q1 '25: 4.20 Q2 '25: 3.59 Q3 '25: 0.39 Q4 '25: 1.39 Q1 '26: 2.28 Q2 '26: 3.79 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.